Change in Director / Key Managerial Personnel

Appointment/Redesignation Details:

  • Mr. Ravindra Kumar Kothari (DIN: 03418320) changed designation from Non-Executive Director to Whole-Time Director, designated as Executive Director, effective October 1, 2026
  • Mr. Virupakshaya Himesh (DIN: 08554422) changed designation from Whole-Time Director to Non-Executive Director, effective October 1, 2026
  • Both directors were re-appointed/re-designated by members at the 39th Annual General Meeting held on September 24, 2026
  • Mr. Ravindra Kumar Kothari was re-appointed as a Director liable to retire by rotation pursuant to Section 152 of the Companies Act, 2013

Approval Process:

  • Changes were recommended by the Nomination and Remuneration Committee at its meeting held on August 12, 2026
  • Subsequently approved by the Board of Directors at its meeting held on August 12, 2026, subject to member approval
  • Final approval obtained from members at the 39th AGM on September 24, 2026

Shareholding Information:

  • Mr. Ravindra Kumar Kothari holds 500 shares in the company
  • Mr. Virupakshaya Himesh holds 28,420 shares in the company

Compliance Status:

  • Both directors are not debarred from holding the office of director by virtue of any SEBI order or any other such authority
  • No relationships between directors disclosed as not applicable

Reconstitution of Statutory Committees

Effective Date: October 1, 2026

Committee Changes:

  • Mr. Virupakshaya Himesh has been inducted as a Member of the Nomination and Remuneration Committee (NRC) and Stakeholders' Relationship Committee (SRC)
  • Mr. Ravindra Kumar Kothari has ceased to be a Member of the NRC and SRC

Approval Process:

  • Proposed reconstitution was recommended by the NRC at its meeting held on August 12, 2026
  • Approved by the Board of Directors at its meeting held on August 12, 2026, subject to member approval for director designation changes
  • Final implementation following member approval at 39th AGM on September 24, 2026

Regulatory Compliance:

  • Reconstitution done in accordance with applicable provisions of the Companies Act, 2013 and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  • Disclosure made pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI LODR Regulations

Scrip Symbol / Code: BALPHARMA / 524824

Date: September 25, 2026